Biosergen Overview
- Year Founded
-
2004
- Status
-
Private
- Employees
-
1
- Latest Deal Type
-
Buyout/LBO
Biosergen General Information
Description
Biosergen AB is a clinical-stage biotechnology company advancing the treatment of life-threatening fungal infections. It has developed the drug candidate BSG005 into a superior antifungal therapy with broader efficacy and improved safety over existing treatments. BSG005 is a drug in the field of antifungals because of its fungicidal effect (it kills the fungus), which is preferable to drugs with a fungistatic effect.
Contact Information
Website
www.biosergen.netCorporate Office
- Fogdevreten 2
- 171 65 Solna
- Sweden
Corporate Office
- Fogdevreten 2
- 171 65 Solna
- Sweden
Biosergen Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Buyout/LBO | 26-Jun-2026 | Completed | Generating Revenue | |||
| 5. PIPE | 03-May-2024 | Completed | Generating Revenue | |||
| 4. IPO | 24-Jun-2021 | Completed | Generating Revenue | |||
| 3. Grant | 01-Dec-2019 | Completed | Generating Revenue | |||
| 2. Later Stage VC | 13-Feb-2013 | Completed | Generating Revenue | |||
| 1. Early Stage VC | Completed | Startup |
Biosergen Patents
Biosergen Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025253319-A1 | Polyene macrolide for use in methods for treatment of fungal infections | Pending | 05-Jun-2024 | ||
| WO-2025172861-A2 | Compositions of a therapeutic polyene macrolide and methods of their use | Pending | 14-Feb-2024 | ||
| WO-2025172861-A3 | Compositions of a therapeutic polyene macrolide and methods of their use | Pending | 14-Feb-2024 | ||
| WO-2025172860-A1 | Polyene macrolide compositions and uses thereof | Pending | 14-Feb-2024 | ||
| CA-3172776-A1 | Pharmaceutical compositions of a therapeutic polyene macrolide and methods of their use | Pending | 26-Feb-2020 | A61K31/7048 |
Biosergen Signals
Biosergen ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
Biosergen FAQs
-
When was Biosergen founded?
Biosergen was founded in 2004.
-
Where is Biosergen headquartered?
Biosergen is headquartered in Solna, Sweden.
-
What is the size of Biosergen?
Biosergen has 1 total employees.
-
What industry is Biosergen in?
Biosergen’s primary industry is Drug Discovery.
-
Is Biosergen a private or public company?
Biosergen is a Private company.
-
What is Biosergen’s current revenue?
The current revenue for Biosergen is .
-
How much funding has Biosergen raised over time?
Biosergen has raised $5.98M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process